| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |